Sterling Trust (Cayman) Ltd. appoints Peter R. Burnim to its Board of Directors

Grand Cayman (MMD Newswire) May 4, 2015 — Sterling Trust (Cayman) Limited, a licensed and regulated Trust and Corporate service provider in the Cayman Islands, announced today that it has appointed Peter R. Burnim to its Board of Directors.

Mr. Burnim is the Managing Director of IQ Venture Partners Inc., and serves on the Boards of Directors of various Allianz Fund Trusts, Argus Group Holdings Limited, and its various subsidiaries, and as Chairman of NGH Ltd. and AISFL. He served as a Director of Sterling Centrecorp, Inc. in Canada for almost a decade.

Mr. Burnim worked at Citibank/Citicorp for over 25 years as Senior Credit, Senior Securities and Senior Corporate Officer. He held positions of increasing responsibility as head of U.S. Corporate Banking, European Corporate Finance, European Capital Markets and U.S. Private Banking. While running the Private Bank in the US., Mr. Burnim’s responsibilities included Citibank’s Trust & Estate Business for High Net Worth Clients.

He has served as an Advisory Board member of CVC Capital Partners (European Buyout Group). He served as a Director of The Bank of Bermuda (NY) Ltd., Argus Insurance Company (Europe) Ltd., and Highland Financial Holdings Fund.

Mr. Burnim is a graduate of Harvard College and Harvard Business School.
Sterling Trust (Cayman) Limited is a fiduciary service provider licensed and regulated by the Cayman Islands Monetary Authority. It was recently acquired by
Sterling Financial Group Inc., an integrated corporate service provider and investment advisory company based in Nassau, in The Bahamas. For more information about Sterling Financial Group Inc. please visit www.sterlingbahamas.com.

Source: Sterling Trust (Cayman) Limited

Possible Bearish Inside Day Candle Pattern Detected for WuXi PharmaTech Cayman (NYSE:WX)

By Shiri Gupta From SmarTrend

Mon, 05/04/2015 – 3:09pm
SmarTrend’s candlestick scanner has spotted a possible bearish inside day candle pattern in WuXi PharmaTech Cayman (NYSE:WX) based on the price action in the company’s shares. Today’s price range of $44.65 and $45.10 is within yesterday’s high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Owners of WuXi PharmaTech Cayman may want to consider a possible hedge in the event a pullback occurs. Look for confirmation in the next few trading days.

WuXi PharmaTech Cayman share prices have moved between a 52-week high of $45.19 and a 52-week low of $29.84 and are now trading 51% above that low price at $44.99 per share. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has declined 0.2%.

WuXi PharmaTech Cayman Inc. provides pharmaceutical and biotechnology research and development outsourcing. The Company’s services include discovery chemistry, service biology, analytical, pharmaceutical development, and manufacturing.

WuXi PharmaTech Cayman (NYSE:WX) is currently priced 9.7% above its average consensus analyst price target of $40.64. The stock should discover initial support at its 50-day moving average (MA) of $38.89 and subsequent support at its 200-day MA of $36.49.

SmarTrend recommended that subscribers consider buying shares of WuXi PharmaTech Cayman on April 6th, 2015 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $39.13. Since that recommendation, shares of WuXi PharmaTech Cayman have risen 15.4%. We continue to monitor WX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

For more on this story go to: http://www.mysmartrend.com/news-briefs/candlestick/possible-bearish-inside-day-candle-pattern-detected-wuxi-pharmatech-cayman–2